JY

Jerry Yang

Description

Jerry Yang

Investor Profile

Jerry Yang has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Genetics.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Genetics
  • Industrial Automation
  • Innovation Management
  • Life Science
  • Machine Learning
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jerry Yang frequently co-invest with?

Alexandria
North America, California, United States, San Francisco
Co-Investments: 1
SciFi VC
North America, California, United States, San Francisco
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
AAF Management Ltd.
North America, District of Columbia, United States, Washington
Co-Investments: 1
AME Cloud Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Menlo Ventures
North America, California, United States, San Francisco
Co-Investments: 1
AI
Europe, Kent, United Kingdom, South Kensington
Co-Investments: 1
WI Harper Group
North America, California, United States, San Francisco
Co-Investments: 1
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Jerry Yang often collaborate with?

JD
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Jerry Yang?

Synthego

Redwood City, California, United States

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Artificial Intelligence (AI)BiotechnologyGeneticsIndustrial AutomationInnovation ManagementLife ScienceMachine LearningSoftware
Series BJan 4, 2017
Amount Raised: $41,000,000